Latitude Advisors »

Vivos Therapeutics shares owned by Latitude Advisors

Quarter-by-quarter ownership of Vivos Therapeutics (VVOS) shares owned by Latitude Advisors from 13F filings

Historical chart of Latitude Advisors investment in Vivos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vivos Therapeutics held by Latitude Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vivos Therapeutics by Latitude Advisors

Quarter filed Position value Share count Share price at filing
2026-09-30 $14 104 0.14

More positions owned by Latitude Advisors

Advisors Inner Circle Fd Ii Pmv Adaptive Rsk (ARP)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Capital Group Dividend Value Shs Creat Unit (CGDV)
NVIDIA Corporation (NVDA)
Spdr Series Trust St Str P500etf (SPYM)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Capital Group Growth Etf Shs Creat Unit (CGGR)
Spdr Gold Tr Gold Shs (GLD)
Apple (AAPL)
Amazon (AMZN)
Capital Group Core Equity Et Shs Creat Unit (CGUS)
Proshares Tr Pshs Ultra Qqq (QLD)
Abbvie (ABBV)

View all positions for Latitude Advisors

Top funds holding Vivos Therapeutics

Geode Capital Management
IHT Wealth Management
Vanguard Capital Management
Commonwealth Equity Services
UBS Group
Centurion Wealth Management
National Asset Management
BlackRock
State Street Corporation
Sequoia Financial Advisors
Vanguard Fiduciary Trust
Northern Trust
Acorn Wealth Advisors
Susquehanna International
HB Wealth Management

View all funds holding Vivos Therapeutics